A new method for preventing restenosis: a single IV injection of drug-loaded nanoparticles.
Park
Kinam
K
Departments of Biomedical Engineering and Pharmaceutics, Indiana, USA.kpark@purdue.edu
D019386:Alendronate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D023903:Coronary Restenosis / Q000517:prevention & control*; D006801:Humans; D007262:Infusions, Intravenous; D009000:Monocytes / Q000166:cytology / Q000187:drug effects; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry*; D011817:Rabbits; D051381:Rats
D019386:Alendronate